This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,172.28, is for the procurement of Medroxyprogesterone 150 mg/ml. It is a firm-fixed-price contract with a completion date of December 12, 2024.
Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.
The contract award does not have a set-aside designation, indicating open competition. As a major supplier to federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen plays a critical role in delivering essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Generated 3/12/25, 9:56 AM